Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amit K Verma
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
508 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Kaiser Permanente-Fontana
Fontana, California, United States
- Marin Cancer Care Inc
Greenbrae, California, United States
- Kaiser Permanente South Bay
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente West Los Angeles
Los Angeles, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Kaiser Permanente - Panorama City
Panorama City, California, United States
- Kaiser Permanente-Riverside
Riverside, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Kaiser Permanente-San Diego Mission
San Diego, California, United States
- Kaiser Permanente-San Diego Zion
San Diego, California, United States
- Kaiser Permanente-San Marcos
San Marcos, California, United States
- Saint Helena Hospital
St. Helena, California, United States
- Presbyterian Intercommunity Hospital
Whittier, California, United States
- Kaiser Permanente-Woodland Hills
Woodland Hills, California, United States
- the Medical Center of Aurora
Aurora, Colorado, United States
- Boulder Community Foothills Hospital
Boulder, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado, United States
- Adventhealth Porter
Denver, Colorado, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Midtown
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Rose
Denver, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jan 2009
- Primary completion
- 8 Jul 2019
- Completion
- 2 Oct 2026
- Last update posted
- 29 May 2026
- Registered enrollment
- 247
- Registry id
- NCT00843882
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.